Delivery Order SPE2DB22D3016-SPE2DB24FBBU0

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026. This particular delivery order is for the pharmaceutical product NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, with a ceiling value of $10,059.36. The contract has a firm fixed price and is not designated as a set-aside. As a major pharmaceutical...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEHG7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,011.96 firm fixed-price delivery order is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a prescription medication, with an ultimate completion date of April 11, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,349.28 fixed-price contract is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialized pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits to support military and government healthcare programs. The $16,964.13 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical and medical products to the Department of Defense. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits to support U.S. government medical requirements. The $21,560.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under an existing Indefinite Delivery Contract (IDC) that has a total potential value of up to $999,999,999 for providing a comprehensive range of pharmaceutical and medical supplies to military treatment programs...
This federal contract award is for the delivery of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $28,718.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the supply of Neulasta OnPro pharmaceutical kits to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is a firm fixed price delivery order valued at $9,183.96, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a medication used to reduce the risk of infection in cancer patients undergoing chemotherapy. The contract has a ceiling value of $13,074.00 and a completion date of July 10, 2025. It is a firm fixed-price contract, which indicates the price is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,465.01 firm-fixed-price delivery order is for the supply of Neupogen 300 mcg/mL vials, a medication used to treat certain types of cancer and other medical conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.78 firm fixed-price delivery order is for the supply of NEUPOGEN 300 MCG/ML VIALML, a specialty pharmaceutical product, with a contract period ending on February 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBBU0
    Delivery Order

This contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,695.17 firm-fixed-price delivery order is for NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty medication, to support military healthcare programs. The award is not designated as a set-aside contract.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/17/25, 9:56 AM